Emkay's research report on DCB Bank
Robust pre-provisioning profit growth, up 35.6% yoy (-0.5% qoq), led by healthy NII (29.6%yoy, 6.4% qoq), strong fee-income (20% yoy, 9.4% qoq) and lower cost-incomeof 61.4% (down 107bps yoy)
SME NPAs of Rs443m were sold to an asset reconstruction company, due to which net slippages were a low Rs69m (0.3% of loans, annualized). Hence, gross NPAs fell 11bps qoq to 1.8% of advances, one of the lowest among peers
The bank is well capitalized with capital adequacy of 15% (tier-1 capital of 14.2%), which is more than sufficient to meet Basel-3 norms and business growth over FY15-17e
We maintain our Buy rating on the stock, as we expect the stock to quote at higher-thanpast valuations led by better-than-past business growth, stable asset quality and greater capital adequacy ahead. At our target of Rs140, the stock would trade at a PABV of 2.1x FY17e
Valuation and risks: "We maintain our Buy rating as we expect robust profitability (1.2% RoA post-tax) over FY15-17E, led by the bank’s prudent business growth strategy, focused network expansion and superior asset quality. We expect the stock to sustain its premium valuations led by stronger business growth, stable asset quality and greater capital adequacy ahead. Our target price of Rs 140 is based on the two-stage dividend-discount model (CoE: 15.9%; beta: 1.2; Rf: 7.5%)", says Emkay Global Financial Services research report.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
